Drugs that are clinically used to treat cardiovascular diseases should be carefully studied because most of the HO-1 inducers such as hemin or tin compounds have limitations resulting from their cellular toxicity or nephrotoxicity, despite their capabilities [33]. The gene discussed is HMOX1; the disease is cardiovascular disorder.